Tender detail
Non-exclusive discount agreement for glatiramer acetate prefilled syringes for 2026–2028
Summary
DAK-Gesundheit intends to conclude a non-exclusive discount agreement with as many interested pharmaceutical companies as possible for medicines containing glatiramer acetate, available only as prefilled syringes (ATC L03AX13). The agreement period runs from 1 December 2026 to 30 November 2028, and the agreement will end earlier if an exclusive agreement for the same active substance takes effect.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.